Table 1.

General feature of FVB and MT mice with or without DAHP treatment for 3 weeks.

Parameter	FVB (34)	MT (34)	FVB-DAHP (32)	MT-DAHP (31)
Body Weight (g)	26.44 ± 0.42	27.48 ± 0.67	26.68 ± 0.45	27.56 ± 0.65
Heart Weight (HW, mg)	153 ± 7	156 ± 8	156 ± 8	148 ± 7
HW/Body Weight (mg/g)	5.77 ± 0.23	5.61 ± 0.20	5.89 ± 0.30	5.41 ± 0.21
Liver Weight (LW, g)	1.42 ± 0.05	1.40 ± 0.07	1.41 ± 0.05	1.38 ± 0.05
LW/Body Weight (mg/g)	53.7 ± 1.7	50.4 ± 1.6	53.1 ± 1.4	50.3 ± 1.4
Kidney Weight (KW, g)	0.341 ± 0.011	0.346 ± 0.014	0.360 ± 0.013	0.369 ± 0.014
KW/Body Weight (mg/g)	12.89 ± 0.30	12.45 ± 0.27	13.60 ± 0.41	13.34 ± 0.31
Systolic BP (mmHg)	103.3 ± 3.1	105.5 ± 3.2	145.8 ± 10.7*	140.5 ± 6.3*
Diastolic BP (mmHg)	72.5 ± 10.0	75.5 ± 5.5	117.0 ± 12.7*	101.8 ± 8.6*
Blood Glucose (mM)	5.10 ± 0.26	5.34 ± 0.27	5.41 ± 0.25	5.22 ± 0.30
Heart Rate (bpm)	545 ± 15	541 ± 20	557 ± 24	544 ± 19
Wall Thickness (mm)	0.871 ± 0.049	0.927 ± 0.063	0.712 ± 0.043*	0.868 ± 0.019†
EDD (mm)	2.32 ± 0.16	2.29 ± 0.21	2.04 ± 0.14	2.24 ± 0.16
ESD (mm)	1.15 ± 0.11	1.11 ± 0.12	1.42 ± 0.09*	1.23 ± 0.10†
LV Mass (mg)	66.9 ± 6.2	62.4 ± 9.2	53.6 ± 9.6	66.9 ± 8.5
Normalized LV Mass (mg/g)	2.35 ± 0.20	2.27 ± 0.30	1.92 ± 0.34	2.42 ± 0.28
Fractional Shortening (%)	50.6 ± 2.6	50.9 ± 4.1	36.7 ± 1.9*	45.3 ± 2.8†

Mean ± SEM,

^*p < 0.05 vs. FVB group,

^†p < 0.05 vs. FVB-DAHP group,

number of mice per group is given in parentheses.